Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar.
Zaqout A, Almaslamani MA, Chemaitelly H, Hashim SA, Ittaman A, Alimam A, Rustom F, Daghfal J, Abukhattab M, AlMukdad S, Kaleeckal AH, Latif AN, Butt AA, Bertollini R, Al-Khal A, Omrani AS, Abu-Raddad LJ.
Zaqout A, et al. Among authors: hashim sa.
Int J Infect Dis. 2022 Nov;124:96-103. doi: 10.1016/j.ijid.2022.09.023. Epub 2022 Sep 19.
Int J Infect Dis. 2022.
PMID: 36218031
Free PMC article.